Asia Pacific Dry Eye Treatment Devices Market Size & Outlook
Asia Pacific dry eye treatment devices market, 2018-2030 (US$M)
Related Markets
Asia Pacific dry eye treatment devices market highlights
- The Asia Pacific dry eye treatment devices market generated a revenue of USD 50.7 million in 2023.
- The market is expected to grow at a CAGR of 8.1% from 2024 to 2030.
- In terms of segment, meibomian gland expression (mgx) was the largest revenue generating technology in 2023.
- Broadband light (BBL) is the most lucrative technology segment registering the fastest growth during the forecast period.
- Country-wise, Japan is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 50.7 million |
| Market revenue in 2030 | USD 87.4 million |
| Growth rate | 8.1% (CAGR from 2023 to 2030) |
| Largest segment | Meibomian gland expression (mgx) |
| Fastest growing segment | Broadband light (BBL) |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Broadband light (BBL), Intense Pulsed Light (IPL), Meibomian Gland Expression (MGX), Combination (MGX+IPL) |
| Key market players worldwide | Sight Sciences Inc, Lumenis, Johnson & Johnson, Alcon Inc, MiBo Medical Group, ESW vision |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 15.7% of the global dry eye treatment devices market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 87.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Dry Eye Treatment Devices Market Scope
Dry Eye Treatment Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific dry eye treatment devices market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dry eye treatment devices market will help companies and investors design strategic landscapes.
Meibomian gland expression (mgx) was the largest segment with a revenue share of 41.42% in 2023. Horizon Databook has segmented the Asia Pacific dry eye treatment devices market based on broadband light (bbl), intense pulsed light (ipl), meibomian gland expression (mgx), combination (mgx+ipl) covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific’s dry eye treatment devices market is expected to grow at the fastest rate of 6.9% during the forecast period. Presence of a large patient pool is expected to drive the demand for these devices. The burden of DED in China, Japan, and India is expected to contribute to the increase in adoption of newer treatment options.
To meet the growing demand, global players are looking to launch technologically advanced devices in the region. For instance, in September 2019, Lumenis announced that it received CFDA Mark for commercial sale of its M22 Optima IPL in China, for treating dry eye. Apart from China, the device is approved for use in South Korea, New Zealand, and Australia.
Reasons to subscribe to Asia Pacific dry eye treatment devices market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific dry eye treatment devices market databook
-
Our clientele includes a mix of dry eye treatment devices market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific dry eye treatment devices market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific dry eye treatment devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific dry eye treatment devices market size, by country, 2018-2030 (US$M)
Asia Pacific Dry Eye Treatment Devices Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
